Originally Published on: Quantzig|How we Helped Pharma Giant Tackle Patient Non-Adherence To Treatment Protocols

Guiding a Multinational Pharma Giant Through Patient Behavior Challenges

Client Landscape: A distinguished multinational pharmaceutical powerhouse headquartered in the USA, boasting an annual revenue exceeding $2 billion and specializing in the rare disease market segment.

Tackling Challenges: Encountering substantial revenue loss attributed to patient non-adherence and elevated churn rates, the client faced the complexity of limited insight into patient behavior. Deciphering the root causes behind non-adherence and churn emerged as a formidable obstacle.

Strategic Interventions: Quantzig collaborated intimately with the pharmaceutical giant, seamlessly integrating and analyzing a diverse array of data sources. This included electronic medical records, patient surveys, prescription data, and demographic information. Through the application of patient journey mapping and digital health for pharma solutions, critical junctures in the healthcare process prone to patient churn or non-adherence were pinpointed. Tailored communication, personalized care, and precisely targeted interventions based on patient segmentation were recommended, resulting in heightened satisfaction, loyalty, and engagement.

Impact Realized: The orchestrated strategic initiatives delivered substantial outcomes:

• 12% Reduction in Patient Churn: Strategic handling of critical touchpoints.
• 10% Increase in Revenue: Implementation of personalized strategies for distinct patient segments.
• Effective Centralized Decision-Making: Augmentation of leadership's capability to drive impactful improvements.

Connect with us for customized solutions! CLICK HERE